PUBLISHER: TechSci Research | PRODUCT CODE: 1309864
PUBLISHER: TechSci Research | PRODUCT CODE: 1309864
We offer 8 hour analyst time for an additional research. Please contact us for the details.
Nucleic Acid Sample Preparation Market is expected to register an impressive CAGR during the forecast period of 2024-2028. This can be attributed to factors such as the growing usage of nucleic acid molecules in various therapeutic areas.
Moreover, other factors, such as growing advancement in nucleic acid extraction and isolation techniques and growing demand for downstream applications such as Next Generation Sequencing (NGS), targeted sequencing, etc., drive the growth of the Nucleic Acid Sample Preparation market.
Increasing investment by the government, academics & institutions, etc., to expand research in life science is expected to drive the market demand for the Nucleic Acid Sample Preparation market. For instance, in February 2022, Brightlamp Inc. and Purdue-affiliated Amplified Sciences LLC received a grant of approximately US$ 250,000 each from the Purdue Foundry Investment Fund for R&D to bring advancement in life sciences. The Amplifies Sciences is researching advancing technology for pre-diagnosis of cancer and other diseases. Similarly, Brightlamp is a company that utilizes machine learning and computer vision to enhance and improve healthcare.
With the growing demand for disease diagnosis on time and the need for diagnostic information in several patient treatments, distinct molecular procedures are developed and thus are increasing the nucleic acid sample extraction to follow the diagnosis procedures and is anticipated to offer lucrative demand to the nucleic acid sample preparation market. Moreover, the growing prevalence of chronic diseases such as cancer is increasing the need for diagnosis at the molecular level, and thus increase in demand for nucleic acid sample extraction and preparation is driving the market growth during the forecast period. Moreover, sample preparation is an essential application in precision medicine on account of its safety assurance level and successful use of tailored therapies.
Nucleic acid isolation /extraction is the most basic step involved in molecular diagnosis or any molecular laboratory research and is expanding with the availability of a distinct range of equipment and methods used for the extraction of samples. The availability of automated nucleic acid extraction systems is bolstering the market growth for the nucleic acid sample preparation market. Moreover, increased automation has leads to running multiple samples at the same time with minimum error ratio and also can extract nucleic acid from distinct samples, such as serum and tissue, cell culture and thus is expected to accelerate the Nucleic Acid Sample Preparation Market. For instance, in February 2020, the market player Covaris Inc. introduced two new kits for viral RNA extraction with throat or nasal swab collection devices, which include the truXTRAC-PCR Direct viral RNA Extraction kit and truXTRAC Viral RNA Extraction kit.
The increased demand for Next-generation Sequencing (NGS) in disease is propelling the demand for the Nucleic Acid Sample Preparation market. The gene or targeted sequence carries a gene or interest or a disease carrier and thus can be identified and used in disease diagnosing. Additionally, targeted sequencing allows researchers to target particular genes of interest, coding areas, and even chromosomal segments, making it a useful technique for sequencing in order to collect accurate, quick, and precise data. The availability of kits and developed reagents for sequencing procedures is attributed to support the market growth and bolster the Nucleic Acid Sample Preparation market during the forecast period.